Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19 Vaccine  Jul 21, 2020  3 years, 8 months, 4 weeks, 1 day, 12 hours, 24 minutes ago

COVID-19 Vaccine: Chinese Ad5 Vectored COVID-19 Vaccine Progresses To Phase 3 As Phase 2 Trial Results Claim To Be Safe and Induces Immune Response

COVID-19 Vaccine: Chinese Ad5 Vectored COVID-19 Vaccine Progresses To Phase 3 As Phase 2 Trial Results Claim To Be Safe and Induces Immune Response
Source: COVID-19 Vaccine  Jul 21, 2020  3 years, 8 months, 4 weeks, 1 day, 12 hours, 24 minutes ago
COVID-19 Vaccine:  The phase 2 trial of China’s Ad5 vectored COVID-19 vaccine candidate that was conducted in Wuhan has found that the vaccine is safe and induces an immune response, according to trial findings published in The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext#%20
 

The phase 2 randomized trial sought to evaluate the safety and immunogenicity of the vaccine candidate and follows a phase 1 trial published in May 2020. The results provide data from a wider group of participants than their phase 1 trial, including a small sub-group of participants aged over 55 years and older, and will inform phase 3 trials of the vaccine.
 
The researchers however note that it is important to stress that no participants were exposed to SARS-CoV-2 virus after vaccination, so it is